scholarly journals Multidimensional Assessment of Tremors in Patient with Multiple Sclerosis

2021 ◽  
Vol 12 (3) ◽  
pp. 648-668
Author(s):  
Asmaa Mohamed ELmzien ◽  
Neamatallah Ahmed Gomaa ◽  
Zeinab Hussein Bakr
2010 ◽  
Vol 12 (1) ◽  
pp. 23-32 ◽  
Author(s):  
Breanne Daudrich ◽  
Danielle Hurl ◽  
Susan Forwell

Tremor is a common symptom of multiple sclerosis (MS) that has debilitating effects on occupational performance and well-being. Tremor is complex, and a valid and reliable assessment tool that takes a multidimensional approach is needed to guide intervention decisions. A new assessment instrument, the Multidimensional Assessment of Tremor (MAT), was designed to measure the severity and functional impact of tremor in people with MS. This study was conducted to introduce this new tool and examine its reliability, validity, and clinical utility. Two clinicians tested the MAT and completed a questionnaire on its clinical utility. During an initial visit, 10 study participants with MS were administered the MAT, which was independently scored by two researchers to determine its inter-rater reliability. Four other tools commonly used to assess tremor were also administered to evaluate the MAT's criterion validity. During a second visit, the MAT was administered a second time to ascertain its test-retest reliability. Study participants demonstrated mild-to-severe tremor with marked functional difficulties. The MAT's inter-rater reliability and test-retest reliability were excellent, while its criterion validity ranged from poor to good. The clinicians, participants, and researchers found the clinical utility of the tool to be good. The MAT offers therapists a clinically useful, evidence-based, and multidimensional tool for evaluating tremor in MS.


Author(s):  
G. Chuprуna ◽  
N. Svyrydova ◽  
N. Petrenko

We studied the prevalence of pain syndromes (РS) in patients with multiple sclerosis (MS) in order to clarify the characteristics of their occurrence and the extent of impact on quality of life, level of fatigue and depression in terms of comorbidity. The study involved 207 MS patients with different forms of course. Evaluated the clinical and demographic characteristics of the patients with MS due to comorbidity, conducted multidimensional assessment of pain using the McGill Pain Questionnaire, determines the level of EDSS, the severity of pain (VAS), the severity of fatigue (FSS), depression (BDI-II), quality of life (SF-36). The average prevalence of РS in all our study patients with MS was 76,3%. It was found that a РS in MS patients are more prevalent in patients with comorbid pathology.


2009 ◽  
Vol 100 (3) ◽  
pp. 156-162 ◽  
Author(s):  
L. Provinciali ◽  
M. G. Ceravolo ◽  
M. Bartolini ◽  
F. Logullo ◽  
M. Danni

1996 ◽  
Vol 22 (3) ◽  
pp. 207-215 ◽  
Author(s):  
H. Li ◽  
M. L. Cuzner ◽  
J. Newcombe
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document